These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21228926)

  • 1. Prognostic value of CD133 expression in stage I lung adenocarcinomas.
    Woo T; Okudela K; Mitsui H; Yazawa T; Ogawa N; Tajiri M; Yamamoto T; Rino Y; Kitamura H; Masuda M
    Int J Clin Exp Pathol; 2010 Dec; 4(1):32-42. PubMed ID: 21228926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas.
    Woo T; Okudela K; Yazawa T; Wada N; Ogawa N; Ishiwa N; Tajiri M; Rino Y; Kitamura H; Masuda M
    Lung Cancer; 2009 Sep; 65(3):355-62. PubMed ID: 19162366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of expression of CD133 and Ki-67 in gastric cancer.
    Saricanbaz I; Karahacioglu E; Ekinci O; Bora H; Kilic D; Akmansu M
    Asian Pac J Cancer Prev; 2014; 15(19):8215-9. PubMed ID: 25339008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance.
    Okudela K; Woo T; Mitsui H; Tajiri M; Masuda M; Ohashi K
    Pathol Int; 2012 Dec; 62(12):792-801. PubMed ID: 23252868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
    Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C
    Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer.
    Wang Q; Chen ZG; Du CZ; Wang HW; Yan L; Gu J
    Histopathology; 2009 Sep; 55(3):284-93. PubMed ID: 19723143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness.
    Zhou X; Li D; Wang X; Zhang B; Zhu H; Zhao J
    Oncotarget; 2015 Feb; 6(5):3111-22. PubMed ID: 25605013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of cancer stem cell marker CD133 expression in non-small cell lung cancer: a systematic review.
    Qu H; Li R; Liu Z; Zhang J; Luo R
    Int J Clin Exp Pathol; 2013; 6(11):2644-50. PubMed ID: 24228135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients.
    Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A
    Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes.
    Roudi R; Korourian A; Shariftabrizi A; Madjd Z
    Cancer Invest; 2015; 33(7):294-302. PubMed ID: 26046383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133 expression is correlated with chemoresistance and early recurrence of gastric cancer.
    Lee HH; Seo KJ; An CH; Kim JS; Jeon HM
    J Surg Oncol; 2012 Dec; 106(8):999-1004. PubMed ID: 22674531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133 expression predicts for non-response to chemotherapy in colorectal cancer.
    Ong CW; Kim LG; Kong HH; Low LY; Iacopetta B; Soong R; Salto-Tellez M
    Mod Pathol; 2010 Mar; 23(3):450-7. PubMed ID: 20081809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of CD133 expression in esophageal squamous cell carcinoma.
    Okamoto H; Fujishima F; Nakamura Y; Zuguchi M; Ozawa Y; Takahashi Y; Miyata G; Kamei T; Nakano T; Taniyama Y; Teshima J; Watanabe M; Sato A; Ohuchi N; Sasano H
    World J Surg Oncol; 2013 Mar; 11():51. PubMed ID: 23448401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis.
    Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X
    J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
    Xi HQ; Zhao P
    J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma.
    Yu JW; Zhang P; Wu JG; Wu SH; Li XQ; Wang ST; Lu RQ; Ni XC; Jiang BJ
    J Exp Clin Cancer Res; 2010 Nov; 29(1):141. PubMed ID: 21054902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma.
    Chan AW; Tong JH; Chan SL; Lai PB; To KF
    Histopathology; 2014 Jun; 64(7):935-50. PubMed ID: 24506513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.